We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Morrison Foerster covers the pharmaceuticals, biologics, diagnostics, personalised medicine, medical devices, medicinal chemicals, and vaccines sectors. The firm is also lauded for its specialisms in IP protection, licensing, pharmacovigilance, and clinical and commercial supply agreements. Other key areas are US-China investigations, drug and device safety, cybersecurity, corruption, compliance, and cross-border transactions. The practice is co-led by managing partner of the Beijing and Shanghai offices, Chuan Sun, who acts for major life sciences clients, including healthcare private equity firms; and Hong Kong-based Gordon Milner, an expert in pharmaceutical and biotechnology industry-related technology projects. Beijing-based Sarah Wang advises on corporate commercial and technology transactions in the life sciences sector; while Chen Zhu and Tyler Xiu are other names in Hong Kong to note.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘MOFO provides very comprehensive legal services to clients.’
‘Chuan Sun is a very experienced healthcare industry lawyer - outstanding.’
Key clients
- Ally Bridge Group
- Celadon Partners
Work highlights
- Advised Jamieson Laboratories and its parent company Jamieson Wellness on their partnership with international private equity firm DCP Capital.
- Advising Celadon Partners on its launch of GeneFab, a contract research, development, and manufacturing organisation (business partnering with the cell and gene therapy industry).